ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is TG Therapeutics, Inc. ?
1
Poor Management Efficiency with a low ROE of 8.40%
- The company has been able to generate a Return on Equity (avg) of 8.40% signifying low profitability per unit of shareholders funds
2
The company has declared negative results in Jun'2026 after 4 consecutive positive quarters
- DEBT-EQUITY RATIO (HY) Highest at 33.47 %
- DEBTORS TURNOVER RATIO(HY) Lowest at 2.53 times
- INTEREST COVERAGE RATIO(Q) Lowest at 131.37
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is TG Therapeutics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
TG Therapeutics, Inc.
62.44%
5.43
46.46%
S&P 500
16.06%
1.20
13.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
261.47%
EBIT Growth (5y)
19.64%
EBIT to Interest (avg)
-23.08
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.13
Sales to Capital Employed (avg)
0.82
Tax Ratio
6.21%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
76.50%
ROCE (avg)
24.02%
ROE (avg)
8.40%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
7.83
EV to EBIT
41.97
EV to EBITDA
41.30
EV to Capital Employed
6.88
EV to Sales
8.40
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
16.38%
ROE (Latest)
69.02%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend14What is working for the Company
NET SALES(Q)
Highest at USD 240.34 MM
CASH AND EQV(HY)
Highest at USD 1,066.68 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 0.93 times
-25What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at 33.47 %
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.53 times
INTEREST COVERAGE RATIO(Q)
Lowest at 131.37
INTEREST(Q)
Highest at USD 16.57 MM
OPERATING PROFIT(Q)
Lowest at USD 21.77 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 9.06 %
PRE-TAX PROFIT(Q)
Lowest at USD 11.46 MM
NET PROFIT(Q)
Lowest at USD 8.71 MM
EPS(Q)
Lowest at USD 0.05
Here's what is working for TG Therapeutics, Inc.
Net Sales
Highest at USD 240.34 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Net Sales
At USD 240.34 MM has Grown at 37.27%
over average net sales of the previous four periods of USD 175.09 MMMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Cash and Eqv
Highest at USD 1,066.68 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 0.93 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for TG Therapeutics, Inc.
Pre-Tax Profit
At USD 11.46 MM has Fallen at -65.57%
over average net sales of the previous four periods of USD 33.29 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD 8.71 MM has Fallen at -92.62%
over average net sales of the previous four periods of USD 118.06 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Interest
At USD 16.57 MM has Grown at 116.18%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Interest Coverage Ratio
Lowest at 131.37
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Debt-Equity Ratio
Highest at 33.47 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio
Lowest at 2.53 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Interest
Highest at USD 16.57 MM
in the last five periods and Increased by 116.18% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Operating Profit
Lowest at USD 21.77 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Operating Profit Margin
Lowest at 9.06 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at USD 11.46 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD 8.71 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
EPS
Lowest at USD 0.05
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
Non Operating Income
Highest at USD 0.62 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
Footer loading
